Dashboard
Manage Tickers

ATAIATAI Life Sciences N.V.

Nasdaq atai.life


$ 1.93 $ 0.09 (4.89 %)    

Friday, 26-Apr-2024 15:26:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 432.04 $ 4.06 (0.95 %)
DIA $ 382.92 $ 2.15 (0.56 %)
SPY $ 509.30 $ 1.11 (0.22 %)
TLT $ 88.26 $ -0.01 (-0.01 %)
GLD $ 216.41 $ -0.84 (-0.39 %)
$ 1.84
$ 1.84
$ 1.92 x 1,400
$ 1.94 x 100
$ 1.84 - $ 1.94
$ 1.03 - $ 2.85
822,238
na
292.25M
$ 1.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-24-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

atai-life-sciences-disclosed-dosing-of-first-patient-in-part-2-of-beckley-psytechs-phase-2a-study-exploring-bpl-003-adjunctive-to-ssris-in-patients-with-treatment-resistant-depression
Atai Life Sciences Disclosed Dosing Of Fir...
04/24/2024 11:08:03

psyched-dea-revisits-ban-on-two-psychedelics-farewell-russell-newcombe-podcast-episode-on-kanna--more
Psyched: DEA Revisits Ban On Two Psychedel...
04/17/2024 12:42:33

atai-life-sciences-announces-the-publication-of-beckley-psytechs-phase-1-study-of-bpl-003-in-the-journal-of-psychopharmacology
ATAI Life Sciences Announces the Publicati...
04/17/2024 11:03:16

atai Life Sciences (NASDAQ:ATAI) ("atai" or "Company"), a clinical-stage biopharmaceutical company aiming to tr...

cantor-fitzgerald-reiterates-overweight-on-atai-life-sciences
Cantor Fitzgerald Reiterates Overweight on...
04/04/2024 13:54:39

Cantor Fitzgerald analyst Charles Duncan reiterates ATAI Life Sciences (NASDAQ:ATAI) with a Overweight.

why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Ulta Beauty Shares Are Trading Lower B...
04/03/2024 17:56:10

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

signet-jewelers-dave--busters-entertainment-blue-owl-capital-and-other-big-stocks-moving-higher-on-wednesday
Signet Jewelers, Dave & Buster's Entertain...
04/03/2024 14:31:14

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.

maxim-group-upgrades-atai-life-sciences-to-buy-announces-6-price-target
Maxim Group Upgrades ATAI Life Sciences to...
04/03/2024 14:02:10

Maxim Group analyst Jason McCarthy upgrades ATAI Life Sciences (NASDAQ:ATAI) from Hold to Buy and announces $6 price target.

hc-wainwright--co-maintains-buy-on-atai-life-sciences-lowers-price-target-to-15
HC Wainwright & Co. Maintains Buy on ATAI ...
04/03/2024 10:55:45

HC Wainwright & Co. analyst Patrick Trucchio maintains ATAI Life Sciences (NASDAQ:ATAI) with a Buy and lowers the price ...

psyched-5-meo-dmt-for-depression-utah-hospitals-providing-therapy-elon-musk-and-metas-influence
Psyched: 5-MeO-DMT For Depression, Utah Ho...
03/29/2024 16:43:17

atai-life-sciences-q4-and-full-year-2023-results-steep-cash-drain-yet-2026-target-remains-update-on-psychedelic-pipeline
Atai Life Sciences Q4 And Full-Year 2023 R...
03/29/2024 13:20:35

intranasal-5-meo-dmt-clinical-trial-offers-hope-for-treatment-resistant-depression
Intranasal 5-MeO-DMT Clinical Trial Offers...
03/28/2024 20:09:24

recap-atai-life-sciences-q4-earnings
Recap: ATAI Life Sciences Q4 Earnings
03/28/2024 11:55:06

atai-life-sciences-q4-eps-012-beats-016-estimate-sales-1800k-miss-19000k-estimate
ATAI Life Sciences Q4 EPS $(0.12) Beats $(...
03/28/2024 11:14:00

ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(...

hc-wainwright--co-maintains-buy-on-atai-life-sciences-maintains-20-price-target
HC Wainwright & Co. Maintains Buy on ATAI ...
03/27/2024 17:49:22

HC Wainwright & Co. analyst Patrick Trucchio maintains ATAI Life Sciences (NASDAQ:ATAI) with a Buy and maintains $20 pri...

psyched-lsd-psilocybin-as-breakthrough-therapies-14m-fed-grant-for-ibogaine-indianas-research-and-more
Psyched: LSD, Psilocybin As Breakthrough T...
03/20/2024 18:49:36

psychedelics-headlines-substitution-survey-frank-herberts-magic-mushrooms-celestial-plans-and-news-review
Psychedelics Headlines: Substitution Surve...
03/16/2024 13:58:40

Core News & Articles
Reported Earlier, 'Indiana Lawmakers Send ...
03/14/2024 16:42:38

https://www.marijuanamoment.net/indiana-lawmakers-send-psilocybin-research-funding-bill-to-governor/   The Indiana legislatur...

psyched-new-evidence-shows-psilocybin-as-anxiety-therapy-open-source-learning-for-therapists-enverics-licensing-deals-and-more
Psyched: New Evidence Shows Psilocybin As ...
03/04/2024 18:48:15

atai-life-sciences-announces-first-participant-dosed-in-phase-1b-trial-of-vls-01
atai Life Sciences Announces First Partici...
03/04/2024 13:08:53

psychedelics-headlines-trauma-informed-care-valentines-day--mdma-academics-on-drugs-and-more
Psychedelics Headlines: Trauma-Informed Ca...
02/15/2024 15:55:16

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION